ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 339 filers reported holding ACCELERON PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $398,000 | -96.7% | 2,314 | -97.4% | 0.00% | -96.1% |
| Q1 2021 | $12,245,000 | +18.7% | 90,295 | -16.6% | 0.05% | -25.0% |
| Q2 2020 | $10,317,000 | +2223.6% | 108,294 | +2090.0% | 0.07% | +2166.7% |
| Q1 2020 | $444,000 | -95.6% | 4,945 | -98.1% | 0.00% | -94.8% |
| Q3 2019 | $10,128,000 | +80.1% | 256,338 | +87.2% | 0.06% | +65.7% |
| Q2 2019 | $5,625,000 | -84.2% | 136,932 | -82.1% | 0.04% | -72.2% |
| Q1 2019 | $35,688,000 | +14466.5% | 766,332 | +13540.7% | 0.13% | +6200.0% |
| Q4 2018 | $245,000 | -95.7% | 5,618 | -95.2% | 0.00% | -93.8% |
| Q2 2018 | $5,710,000 | -3.4% | 117,693 | -26.3% | 0.03% | -13.5% |
| Q3 2017 | $5,913,000 | +763.2% | 159,799 | +599.9% | 0.04% | +640.0% |
| Q2 2017 | $685,000 | -61.0% | 22,833 | -66.2% | 0.01% | -64.3% |
| Q1 2017 | $1,757,000 | – | 67,563 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,080,113 | $50,301,000 | 4.98% |
| Foresite Capital Management II, LLC | 188,602 | $8,783,000 | 3.96% |
| Artal Group S.A. | 1,650,000 | $76,841,000 | 3.14% |
| Foresite Capital Management III, LLC | 254,923 | $11,872,000 | 3.09% |
| Asymmetry Capital Management, L.P. | 30,125 | $1,403,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,255,174 | $58,453,000 | 2.24% |
| QVT Financial LP | 190,977 | $8,894,000 | 2.24% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $12,546,000 | 1.51% |
| Novo Holdings A/S | 198,261 | $9,233,000 | 1.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,375,000 | $110,604,000 | 0.83% |